(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Effect of L- and S-endoglin on collagen I and CTGF expression. (A,B) Mock, L- and S-endoglin cells were treated (T) or not (C) with TGFβ1 for 24 hours in serum-free medium. Total protein extracts were analyzed by western blot using a specific antibody for collagen I (A) or CTGF (B). Measures of densitometry of each band were performed and relative values are represented. Collagen I and CTGF histogram represents the mean of three different extracts. (C) L6E9 cells were transfected with a vector expressing either caALK1 or caALK5, and collagen expression analyzed by western blot. (D) Mock, L-Endo and S-Endo-transfected cells were treated with the ALK5 inhibitor SB431542 (SB, 5 µM) 1 hour before treatment with TGFβ1. Total protein extracts from control (C) or TGFβ1-treated (T) myoblasts were analyzed by western blot with anti-collagen I and anti-tubulin antibodies. A representative blot from three independent experiments is shown. The blot of the S-endoglin samples is under-exposed in order to visualize the differences caused by the SB431542 treatment.